These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38612543)

  • 41. High-end arteriolar resistance limits uterine artery blood flow and restricts fetal growth in preeclampsia and gestational hypertension at high altitude.
    Browne VA; Toledo-Jaldin L; Davila RD; Lopez LP; Yamashiro H; Cioffi-Ragan D; Julian CG; Wilson MJ; Bigham AW; Shriver MD; Honigman B; Vargas E; Roach R; Moore LG
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1221-9. PubMed ID: 21325643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
    Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
    Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eucommia granules activate Wnt/β-catenin pathway, and improve oxidative stress, inflammation, and endothelial injury in preeclampsia rats.
    Huang X; Xing G; Zhang C; Sun X
    Acta Cir Bras; 2024; 39():e391524. PubMed ID: 38629649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas.
    Napolitano M; Miceli F; Calce A; Vacca A; Gulino A; Apa R; Lanzone A
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2318-23. PubMed ID: 10852470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia.
    Alpoim PN; Perucci LO; Godoi LC; Goulart COL; Dusse LMS
    Clin Chim Acta; 2018 Aug; 483():234-238. PubMed ID: 29723511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
    Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
    Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of maternal plasma platelet activating factor acetylhydrolase activity and mRNA expression in pre-eclampsia: a case control study.
    Gupta P; Agarwal R; Bhaskaran S; Garg S; Mehndiratta M; Radhakrishnan G; Singh A; Agarwal R; Narang D
    J Obstet Gynaecol; 2021 Jul; 41(5):726-732. PubMed ID: 33073639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiological characterization of an arginine vasopressin rat model of preeclampsia.
    Ramdin S; Naicker T; Pillay V; Singh SD; Baijnath S; Mkhwanazi BN; Govender N
    Syst Biol Reprod Med; 2022 Feb; 68(1):55-69. PubMed ID: 34743622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up.
    Fruci S; Salvi S; Moresi S; Gallini F; Dell'Aquila M; Arena V; Di Stasio E; Ferrazzani S; De Carolis S; Lanzone A
    Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():37-42. PubMed ID: 36764034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radicals, Oxidative/Nitrosative Stress and Preeclampsia.
    Taysi S; Tascan AS; Ugur MG; Demir M
    Mini Rev Med Chem; 2019; 19(3):178-193. PubMed ID: 30324879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress changes in pregnant patients with and without severe preeclampsia.
    Bazavilvaso-Rodríguez MA; Hernández-Valencia M; Santillan-Morelos JG; Galvan-Duarte RE; Campos-León S; Lemus-Rocha SR; Saucedo R; Zarate A
    Arch Med Res; 2011 Apr; 42(3):195-8. PubMed ID: 21722814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.
    Manuelpillai U; Schneider-Kolsky M; Dole A; Wallace EM
    J Endocrinol; 2001 Oct; 171(1):57-64. PubMed ID: 11572790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidative stress in early pregnancy and the risk of preeclampsia.
    Ahmad IM; Zimmerman MC; Moore TA
    Pregnancy Hypertens; 2019 Oct; 18():99-102. PubMed ID: 31586785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemorheological changes in women with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Hemorheol Microcirc; 2004; 31(1):49-58. PubMed ID: 15272153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis.
    Dunk CE; Bucher M; Zhang J; Hayder H; Geraghty DE; Lye SJ; Myatt L; Hackmon R
    Am J Obstet Gynecol; 2022 Oct; 227(4):641.e1-641.e13. PubMed ID: 35863458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of experimental microfluidic device and methodology for assessing microrheological properties of blood.
    Antonova N; Khristov K; Alexandrova A; Muravyov A; Velcheva I
    Clin Hemorheol Microcirc; 2023; 83(3):231-245. PubMed ID: 36565107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence of sexual dimorphism in the placental function with severe preeclampsia.
    Muralimanoharan S; Maloyan A; Myatt L
    Placenta; 2013 Dec; 34(12):1183-9. PubMed ID: 24140080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
    Estellés A; Gilabert J; Aznar J; Loskutoff DJ; Schleef RR
    Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.
    Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.